| Financial Year |
March 31 2023 |
| Monetary Funds |
4,139,271,722.10 |
| Held-for-trading Financial Assets |
5,940,111.51 |
| Notes Receivable |
4,833,428.95 |
| Accounts Receivable |
623,782,320.92 |
| Advances to Suppliers |
19,491,792.38 |
| Other Receivables |
124,477,822.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,593,337,128.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
239,476,368.01 |
| Total Current Assets |
8,784,983,941.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
52,797,633.52 |
| Long-term Equity Investment |
353,165,218.58 |
| Investment Properties |
37,941,463.50 |
| Fixed Assetes |
86,333,212.28 |
| Under-construction Projects |
46,804,247.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
733,229,692.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,368,654.12 |
| Deferred Income Tax Assets |
11,079,954.61 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,344,867,583.24 |
| Total Assets |
10,129,851,524.98 |
| Short-Term Loans |
1,285,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,361,172.30 |
| Accounts Payable |
1,764,038,240.01 |
| Accounts Received In Advance |
20,743,863.00 |
| Employee Compensation Payable |
5,215,839.40 |
| Taxes Payable |
103,857,460.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
345,543,153.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,158,909.98 |
| Other Current Liabilities |
161,103,585.42 |
| Sub-Total of Current Liabilities |
6,409,752,962.52 |
| Long-term Loans |
33,458,809.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,339,726.31 |
| Total Liabilities |
6,450,092,688.83 |
| Paid-In Capital(Or Share Stock) |
624,761,516.00 |
| Capital Surplus |
22,542,135.33 |
| Surplus Reserve |
300,512,621.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,686,507,905.94 |
| Minority Stockholder's Interest |
44,470,561.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,635,288,274.71 |
| Owner's Equity（Stockholder's Equity） |
3,679,758,836.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,129,851,524.98 |
